162 related articles for article (PubMed ID: 37499753)
1. GDF15 Ameliorates Liver Fibrosis by Metabolic Reprogramming of Macrophages to Acquire Anti-Inflammatory Properties.
Li X; Huai Q; Zhu C; Zhang X; Xu W; Dai H; Wang H
Cell Mol Gastroenterol Hepatol; 2023; 16(5):711-734. PubMed ID: 37499753
[TBL] [Abstract][Full Text] [Related]
2. GDF15 deficiency exacerbates chronic alcohol- and carbon tetrachloride-induced liver injury.
Chung HK; Kim JT; Kim HW; Kwon M; Kim SY; Shong M; Kim KS; Yi HS
Sci Rep; 2017 Dec; 7(1):17238. PubMed ID: 29222479
[TBL] [Abstract][Full Text] [Related]
3. Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice.
Kim KH; Kim SH; Han DH; Jo YS; Lee YH; Lee MS
Sci Rep; 2018 May; 8(1):6789. PubMed ID: 29717162
[TBL] [Abstract][Full Text] [Related]
4. PSMP/MSMP promotes hepatic fibrosis through CCR2 and represents a novel therapeutic target.
She S; Wu X; Zheng D; Pei X; Ma J; Sun Y; Zhou J; Nong L; Guo C; Lv P; Song Q; Zheng C; Liang W; Huang S; Li Q; Liu Z; Song Z; Li Y; Zhang Y; Kong W; You H; Xi J; Wang Y
J Hepatol; 2020 Mar; 72(3):506-518. PubMed ID: 31813573
[TBL] [Abstract][Full Text] [Related]
5. Identification of growth differentiation factor 15 as a pro-fibrotic factor in mouse liver fibrosis progression.
Qi P; Ma MZ; Kuai JH
Int J Exp Pathol; 2021 Jun; 102(3):148-156. PubMed ID: 33983642
[TBL] [Abstract][Full Text] [Related]
6. Glycoprotein Nonmetastatic Melanoma B (Gpnmb)-Positive Macrophages Contribute to the Balance between Fibrosis and Fibrolysis during the Repair of Acute Liver Injury in Mice.
Kumagai K; Tabu K; Sasaki F; Takami Y; Morinaga Y; Mawatari S; Hashimoto S; Tanoue S; Kanmura S; Tamai T; Moriuchi A; Uto H; Tsubouchi H; Ido A
PLoS One; 2015; 10(11):e0143413. PubMed ID: 26599547
[TBL] [Abstract][Full Text] [Related]
7. Smad7 Deficiency in Myeloid Cells Does Not Affect Liver Injury, Inflammation or Fibrosis after Chronic CCl
Unrau L; Endig J; Goltz D; Sprezyna P; Ulrich H; Hagenstein J; Geers B; Kaftan K; Heukamp LC; Tiegs G; Diehl L
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769006
[TBL] [Abstract][Full Text] [Related]
8. Cav-1 deficiency promotes liver fibrosis in carbon tetrachloride (CCl
Ji DG; Zhang Y; Yao SM; Zhai XJ; Zhang LR; Zhang YZ; Li H
Biomed Pharmacother; 2018 Jun; 102():26-33. PubMed ID: 29549726
[TBL] [Abstract][Full Text] [Related]
9. TREM2 protects against inflammation by regulating the release of mito-DAMPs from hepatocytes during liver fibrosis.
Shan S; Chao S; Liu Z; Wang S; Liu Z; Zhang C; Cheng D; Su Z; Song F
Free Radic Biol Med; 2024 Aug; 220():154-165. PubMed ID: 38710340
[TBL] [Abstract][Full Text] [Related]
10. Identification of a distinct cluster of GDF15
Dai C; Zhang H; Zheng Z; Li CG; Ma M; Gao H; Zhang Q; Jiang F; Cui X
Front Immunol; 2024; 15():1309739. PubMed ID: 38655264
[TBL] [Abstract][Full Text] [Related]
11. Cell-specific PPARγ deficiency establishes anti-inflammatory and anti-fibrogenic properties for this nuclear receptor in non-parenchymal liver cells.
Morán-Salvador E; Titos E; Rius B; González-Périz A; García-Alonso V; López-Vicario C; Miquel R; Barak Y; Arroyo V; Clària J
J Hepatol; 2013 Nov; 59(5):1045-53. PubMed ID: 23831119
[TBL] [Abstract][Full Text] [Related]
12. Glabridin inhibits liver fibrosis and hepatic stellate cells activation through suppression of inflammation and oxidative stress by activating PPARγ in carbon tetrachloride-treated mice.
Zhang L; Zhang H; Gu J; Xu W; Yuan N; Sun J; Li H
Int Immunopharmacol; 2022 Dec; 113(Pt B):109433. PubMed ID: 36371863
[TBL] [Abstract][Full Text] [Related]
13. Involvement of TGF-β1/Smad3 Signaling in Carbon Tetrachloride-Induced Acute Liver Injury in Mice.
Niu L; Cui X; Qi Y; Xie D; Wu Q; Chen X; Ge J; Liu Z
PLoS One; 2016; 11(5):e0156090. PubMed ID: 27224286
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine kinase inhibitor BIBF1120 ameliorates inflammation, angiogenesis and fibrosis in CCl
Öztürk Akcora B; Storm G; Prakash J; Bansal R
Sci Rep; 2017 Mar; 7():44545. PubMed ID: 28291245
[TBL] [Abstract][Full Text] [Related]
15. TG101348, a selective JAK2 antagonist, ameliorates hepatic fibrogenesis
Akcora BÖ; Dathathri E; Ortiz-Perez A; Gabriël AV; Storm G; Prakash J; Bansal R
FASEB J; 2019 Aug; 33(8):9466-9475. PubMed ID: 31100032
[TBL] [Abstract][Full Text] [Related]
16. Hepatoprotective effect of total flavonoids of Mallotus apelta (Lour.) Muell.Arg. leaf against carbon tetrachloride-induced liver fibrosis in rats via modulation of TGF-β1/Smad and NF-κB signaling pathways.
Zhang B; Lai L; Tan Y; Liang Q; Bai F; Mai W; Huang Q; Ye Y
J Ethnopharmacol; 2020 May; 254():112714. PubMed ID: 32105750
[TBL] [Abstract][Full Text] [Related]
17. Glutamine inhibits CCl4 induced liver fibrosis in mice and TGF-β1 mediated epithelial-mesenchymal transition in mouse hepatocytes.
Shrestha N; Chand L; Han MK; Lee SO; Kim CY; Jeong YJ
Food Chem Toxicol; 2016 Jul; 93():129-37. PubMed ID: 27137983
[TBL] [Abstract][Full Text] [Related]
18. Growth differentiation factor 15 facilitates lung fibrosis by activating macrophages and fibroblasts.
Takenouchi Y; Kitakaze K; Tsuboi K; Okamoto Y
Exp Cell Res; 2020 Jun; 391(2):112010. PubMed ID: 32305327
[TBL] [Abstract][Full Text] [Related]
19. ARRB1 inhibits non-alcoholic steatohepatitis progression by promoting GDF15 maturation.
Zhang Z; Xu X; Tian W; Jiang R; Lu Y; Sun Q; Fu R; He Q; Wang J; Liu Y; Yu H; Sun B
J Hepatol; 2020 May; 72(5):976-989. PubMed ID: 31857195
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of growth differentiation factor 15 in sepsis by regulating macrophage polarization and its mechanism.
Zhang X; Dong S
Bioengineered; 2022 Apr; 13(4):9687-9707. PubMed ID: 35420978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
